SequelSEC

SBC Medical Group Holdings Inc SBC

Services-Offices & Clinics of Doctors of Medicine · CIK 0001930313 · Fiscal year ends 1231

Revenue
$173.61M
Fiscal year ended 2025-12-31
Operating income
$67.49M
Fiscal year ended 2025-12-31
Free cash flow
$23.27M
Fiscal year ended 2025-12-31

SBC Medical Group Holdings Inc (SBC) reported revenue of $173.61M and net income of $50.99M for the fiscal year ended 2025-12-31. This page shows 3 annual periods of income statement, balance sheet and cash flow figures normalized from SBC Medical Group Holdings Inc’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Offices & Clinics of Doctors of Medicine.

Income

SBC Medical Group Holdings Inc income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-31
Revenue$173.61M$205.42M$193.54M
Cost of revenue$46.32M$49.37M$56.24M
Gross profit$127.28M$156.05M$137.30M
Operating income$67.49M$70.30M$70.66M
Net income$50.99M$46.61M$39.37M
Research & developmentUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 103.00Mshares 96.56Mshares 94.19M
Pretax income$82.07M$73.46M$73.58M
Income tax expense$31.02M$26.77M$35.02M
Diluted EPS$0.50$0.48$0.42
Selling, general & administrative$59.80M$57.67M$66.23M
General & administrativeUnavailableUnavailableUnavailable
Selling & marketingUnavailableUnavailableUnavailable

Balance

SBC Medical Group Holdings Inc balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-31
Cash & equivalents$163.77M$125.04M$103.02M
Total assets$380.45M$266.08M$258.81M
Current assets$231.22M$184.45M$165.91M
Total liabilities$117.14M$71.06M$115.00M
Current liabilities$61.12M$61.19M$92.45M
Total equity incl. NCI$263.30M$195.02M$143.81M
Temporary (mezzanine) equityUnavailableUnavailable$20.61M
Inventory$2.79M$1.49M$3.09M
Accounts receivableUnavailableUnavailableUnavailable
Goodwill$15.43M$4.61M$3.59M
Long-term debt$42.83M$6.60MUnavailable
Accounts payableUnavailableUnavailable$26.53M

Cash flow

SBC Medical Group Holdings Inc cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-31
Operating cash flow$24.67M$20.58M$50.67M
Capital expenditures$1.40M$2.56M$8.54M
Investing cash flow-$20.97M-$10.10M$1.79M
Financing cash flow$38.29M$22.97M$6.14M
Net change in cash$38.73M$22.02M$51.28M
Stock-based compensation$0$13.02MUnavailable
Common dividends paidUnavailableUnavailableUnavailable
Common share repurchases$5.00M$0Unavailable
Depreciation & amortization$2.68M$3.80M$12.25M

Derived

SBC Medical Group Holdings Inc derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-31
Free cash flow$23.27M$18.02M$42.13M
Gross margin73.3%76.0%70.9%
Operating margin38.9%34.2%36.5%
FCF margin13.4%8.8%21.8%
SBC / revenue0.0%6.3%Unavailable
Current ratio3.78x3.01x1.79x
Revenue YoY growth-15.5%6.1%Unavailable
Net margin29.4%22.7%20.3%
R&D / revenueUnavailableUnavailableUnavailable
CapEx / revenue0.8%1.2%4.4%
Long-term debt / equityUnavailableUnavailableUnavailable
Effective tax rate37.8%36.4%47.6%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open SBC in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-13View SEC filing
10-Q · Filed 2026-05-14View SEC filing
10-K · Filed 2026-03-27View SEC filing
10-Q · Filed 2025-11-14View SEC filing
10-Q · Filed 2025-08-13View SEC filing
10-Q · Filed 2025-05-15View SEC filing

Companies in the same industry

Reconciliation checks needing review

1 period on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

balance equationreview2023-12-31

Difference 20606204 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.